Stockscreener 앱 받기
26.32
0.79%
0.205
전일 마감가:
$26.11
열려 있는:
$25.99
하루 거래량:
2.49M
Relative Volume:
0.99
시가총액:
$2.37B
수익:
-
순이익/손실:
$-95.90M
주가수익비율:
-19.94
EPS:
-1.32
순현금흐름:
$-79.09M
1주 성능:
+16.64%
1개월 성능:
+224.08%
6개월 성능:
+778.63%
1년 성능:
+360.86%
1일 변동 폭
$25.31
$26.51
1주일 범위
$22.63
$28.49
52주 변동 폭
$1.865
$28.49
턴스 파마슈티컬스 Stock (TERN) Company Profile
명칭
Terns Pharmaceuticals Inc
전화
650-525-5535 EXT.101
주소
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
TERN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
26.32 | 2.35B | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
턴스 파마슈티컬스 Stock (TERN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-04 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2025-11-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2025-10-15 | 개시 | Truist | Buy |
| 2025-09-17 | 개시 | Barclays | Overweight |
| 2025-09-04 | 재개 | H.C. Wainwright | Neutral |
| 2025-02-28 | 개시 | William Blair | Mkt Perform |
| 2024-10-31 | 개시 | Oppenheimer | Outperform |
| 2023-06-22 | 개시 | Mizuho | Buy |
| 2023-06-07 | 개시 | Jefferies | Buy |
| 2023-05-31 | 개시 | ROTH MKM | Buy |
| 2023-05-08 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-14 | 개시 | JMP Securities | Mkt Outperform |
| 2023-02-07 | 개시 | UBS | Buy |
| 2022-09-12 | 개시 | H.C. Wainwright | Neutral |
| 2021-09-14 | 재개 | Goldman | Buy |
| 2021-03-02 | 개시 | Cowen | Outperform |
| 2021-03-02 | 개시 | Goldman | Buy |
| 2021-03-02 | 개시 | JP Morgan | Overweight |
모두보기
턴스 파마슈티컬스 주식(TERN)의 최신 뉴스
What drives Terns Pharmaceuticals Inc stock priceEarnings Volatility Patterns & Explosive Profit Growth - earlytimes.in
10 Hottest SMID-Cap Stocks So Far In 2025 - Insider Monkey
First Week of July 2026 Options Trading For Terns Pharmaceuticals (TERN) - Nasdaq
Applying Wyckoff theory to Terns Pharmaceuticals Inc. stock2025 Buyback Activity & Expert Curated Trade Setup Alerts - newser.com
Is Terns Pharmaceuticals Inc. stock cheap at current valuationAnalyst Downgrade & Risk Controlled Daily Plans - newser.com
Is Terns Pharmaceuticals Inc. stock a top momentum playJuly 2025 Fed Impact & Weekly Setup with ROI Potential - newser.com
How hedge fund analytics apply to Terns Pharmaceuticals Inc. stock2025 Institutional Moves & Short-Term Trading Alerts - newser.com
Advanced analytics toolkit walkthrough for Terns Pharmaceuticals Inc.Market Rally & AI Driven Price Predictions - newser.com
Is Terns Pharmaceuticals Inc. still worth holding after the dipQuarterly Profit Report & AI Based Buy/Sell Signal Reports - newser.com
What Wall Street predicts for Terns Pharmaceuticals Inc. stock priceJuly 2025 Movers & Smart Swing Trading Techniques - newser.com
How sentiment analysis helps forecast Terns Pharmaceuticals Inc.Long Setup & AI Enhanced Market Trend Forecasts - newser.com
Terns Pharma (TERN) Sees Target Price Raised by Truist Securities | TERN Stock News - GuruFocus
Truist Securities raises Terns Pharmaceuticals stock price target to $35 on positive ASH data - Investing.com Canada
Terns Pharmaceuticals stock hits 52-week high at 27.8 USD By Investing.com - Investing.com Nigeria
Terns Pharmaceuticals stock hits 52-week high at 27.8 USD - Investing.com
Truist Raises Price Target on Terns Pharmaceuticals to $35 From $28, Keeps Buy Rating - MarketScreener
How Terns Pharmaceuticals Inc. stock reacts to Fed rate cutsWeekly Risk Summary & Reliable Intraday Trade Alerts - newser.com
Relative strength of Terns Pharmaceuticals Inc. in sector analysis2025 Market Outlook & Growth Focused Investment Plans - newser.com
From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews
Could Positive Early Data for TERN-701 Shift Terns Pharmaceuticals' (TERN) Long-Term Competitive Position? - Yahoo Finance
BMO Capital Maintains Terns Pharmaceuticals (TERN) Outperform Recommendation - Nasdaq
Terns Pharma (TERN) Sees Rating Maintained but Price Target Rais - GuruFocus
Commit To Buy Terns Pharmaceuticals At $20, Earn 36.5% Annualized Using Options - Nasdaq
Terns Pharmaceuticals (TERN) Soars to New Record High of $26.12 - Finviz
TERN: 64% response in refractory CML and strong safety drive rapid pivotal trial plans - TradingView
William Blair Reiterates a Buy on Terns Pharmaceuticals (TERN) - MSN
Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday - Benzinga
Terns Pharmaceuticals (TERN) Price Target Increased by 65.68% to 26.75 - Nasdaq
Will Terns Pharmaceuticals Inc. stock recover after recent dropTrade Risk Summary & Technical Pattern Based Signals - newser.com
10 Hottest Small Cap Stocks to Buy Now - Insider Monkey
턴스 파마슈티컬스 (TERN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
1.42%
자본화:
|
볼륨(24시간):